Date | Name | Title | Action | No Shares | Price Per Share |
---|---|---|---|---|---|
Insider Transactions For LGND | |||||
2025-09-23 | Aryeh, Jason | Director | Sold | 4628 | $170.96 |
2025-09-23 | Aryeh, Jason | Director | Sold | 4418 | $170.41 |
2025-09-23 | Aryeh, Jason | Director | Sold | 954 | $171.92 |
2025-09-22 | Zimmermann, Martine | Director | Sold | 115 | $170.77 |
2025-09-02 | Kozarich, John W | Director | Sold | 267 | $161.51 |
2025-09-02 | Kozarich, John W | Director | Sold | 115 | $162.52 |
2025-09-02 | Kozarich, John W | Director | Sold | 85 | $164.25 |
2025-08-10 | Reardon, Andrew | CLO & Secretary | Sold | 1325 | $150.06 |
2025-08-01 | Kozarich, John W | Director | Sold | 467 | $131.88 |
2025-07-10 | Kozarich, John W | Director | Sold | 934 | $125.00 |
2025-07-01 | Ligand, Pharmaceuticals Inc | 10% Owner | Purchased | 1500000 | $10.00 |
2025-07-01 | Ligand, Pharmaceuticals Inc | 10% Owner | Sold | 15000 | $0.00 |
2025-07-01 | Ligand, Pharmaceuticals Inc | 10% Owner | Purchased | 31278.68 | $0.00 |
2025-06-30 | Davis, Todd C | Director, Chief Executive Officer | Purchased | 233 | $91.08 |
2025-06-30 | Espinoza, Octavio | Chief Financial Officer | Purchased | 224 | $91.08 |
2025-06-30 | Reardon, Andrew | CLO & Secretary | Purchased | 233 | $91.08 |
2025-06-23 | Reardon, Andrew | CLO & Secretary | Sold | 500 | $114.08 |
2025-06-10 | Reardon, Andrew | CLO & Secretary | Sold | 500 | $114.54 |
2025-06-06 | Gray, Nancy Ryan | Director | Purchased | 5783 | $0.00 |
2025-06-06 | Gray, Nancy Ryan | Director | Purchased | 1209 | $0.00 |